Appetite and ghrelin levels in iron deficiency anemia and the effect of parenteral iron therapy: A longitudinal study.

Hanin GhrayebMazen EliasJeries NashashibiAwni YoussefMari ManalLiala MahagnaMasalha RefaatNaama SchwartzAdi Elias

Published in: PloS one (2020)

IDA patients have a reduced appetite and paradoxically elevated ghrelin hormone activity compared to healthy controls. Treating IDA enhances appetite and lowers ghrelin levels. Future studies are needed to explore the mechanism of this paradoxical ghrelin activity.

Keyphrases

iron deficiency
end stage renal disease
weight loss
chronic kidney disease
body weight
ejection fraction
newly diagnosed
growth hormone
prognostic factors
stem cells
cell therapy